blood glutathione concentrations in a large-scale human study Targeted Metabolomic Assessment of Oral Bioavailability and Safety Humans: A Randomized Crossover Clinical Trial A mathematical model of glutathione

The April 2026 FDA action removes them from the Category 2 restricted compounding list effective April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review their compounding eligibility under 503A at its July 23-24, 2026 meeting

Yang XB, Bhatnagar RS, Li S, Oreffo RO

Calm irritation and redness

No refrigeration needed

PMC 3756590

Studies show it may be well tolerated in higher doses of 700mg three times a day, as well, with few to no adverse effects when taken as an oral supplement (but we dont recommend taking more than what a supplement manufacturer instructs).31 That's not to say that adverse effects aren't out of the question